Skip to main content
. 2020 Aug 24;10:14145. doi: 10.1038/s41598-020-71062-2

Figure 2.

Figure 2

FAM83H-AS1 over-expression is a marker for poor prognosis in ER/PR BRCA patients. (A) Overall survival analysis (Cox Regression) for the BRCA TCGA cohort. (B) Kaplan–Meier analysis for our independent BRCA cohort. (C) Kaplan–Meier analysis for PR and D, ER positive BRCA patients from the TCGA cohort. (E) FAM83H-AS1 expression is associated with tamoxifen resistance in BRCA patients.